AGIO AGIOS PHARMACEUTICALS, INC.: institutional ownership and insider trading
254 funds reported holding $2.82B of AGIOS PHARMACEUTICALS, INC. in their latest 13F filings; in Q2 2026 funds net bought $101M, with 33 new positions and 32 funds selling out; over the last 12 months insiders bought $0 and sold $4.83M on the open market; over its last four quarters it reported revenue of $98.3M and net income of −$412M.
AGIO revenue and earnings
- Quarter ended Jun 30, 2026: revenue $44.7M, net income −$101M, EPS -1.69
- Quarter ended Mar 31, 2026: revenue $20.7M, net income −$99.1M, EPS -1.69
- Quarter ended Dec 31, 2025: revenue $20.0M, net income −$108M, EPS -1.86
- Quarter ended Sep 30, 2025: revenue $12.9M, net income −$103M, EPS -1.78
Famous investors holding AGIO
- D. E. Shaw (D. E. Shaw & Co.): $115M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $19.9M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $33.9M, 0.0% of the portfolio
Largest institutional holders of AGIO
- BlackRock, Inc. (BLK) — $240M
- FARALLON CAPITAL MANAGEMENT, L.L.C. — $220M
- ARMISTICE CAPITAL, LLC — $193M
- VANGUARD GROUP INC — $152M
- STATE STREET CORP (STT, STT-PG) — $131M
- Lynx1 Capital Management LP — $127M
- D. E. Shaw & Co., Inc. — $115M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $108M
- VANGUARD CAPITAL MANAGEMENT LLC — $99.5M
- Erste Asset Management GmbH — $82.0M
Recent AGIO insider trades
- Oct 22, 2026: Gheuens Sarah sold 1,989 shares ($74.6K)
- Aug 4, 2026: Gheuens Sarah sold 30,000 shares ($914K)
- Jul 1, 2026: Gheuens Sarah sold 4,007 shares ($151K)
- Apr 2, 2026: Goff Brian sold 19,068 shares ($662K)
Members of Congress trading AGIO
- Aug 20, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Mar 3, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Dec 11, 2025: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Apr 17, 2025: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Jan 29, 2025: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Jan 24, 2024: Josh Gottheimer bought $1.00K–$15.0K
5%+ owners
- Farallon Capital Management, L.L.C.: 9.9% (Schedule 13G/A, filed Aug 3, 2026)
- Vanguard Capital Management: 5.3% (Schedule 13G, filed Apr 29, 2026)
- D. E. Shaw & Co., L.P.: 5.1% (Schedule 13G, filed Jul 2, 2026)
- Lynx1 Capital Management LP: 5.1% (Schedule 13G, filed May 6, 2026)